Autism StudiesCurrent Studies in Progress Functional MRI Evaluation of the Effects of Aripiprizole in Autism Spectrum Disorders Individuals with high-functioning autism (males and females 10-55 years old) will be recruited for a study that will use harmless and non-invasive brain imaging (functional MRI) to investigate how aripiprizole (also known as Abilify(r)) helps to reduce symptoms of restricted interests and repetitive behaviors. Read more >> Ages: 10 - 55 years Social Cognition and Interaction Training for Adolescents with High Functioning Autism (SCIT-A) Teens diagnosed with High Functioning Autism and Asperger’s Syndrome (17-20 years old) will be recruited for a 12 – 16 week study to improve social skills through a group-based social cognitive intervention. Read more >> Ages: 17 - 20 years
The goal of the current research project is to increase our understanding of normal brain development and how the brain develops in children with autism and developmental delay. This new information will provide clues about how brain development may differ for individuals with autism and related disorders. Read more >>
SOFIA Study In this study we are trying to determine what the effects of taking Prozac (fluoxetine ODT) are on repetitive behaviors in children diagnosed with an autism spectrum disorder. Cure Autism Now/Autism Speaks have partnered with a pharmaceutical company in order to better determine what effects this medicine has on treating symptoms related to autism. The medicine is a quick dissolving tablet that disappears in seconds once placed on the tongue. Read more >> Ages: 5-17 years Note: This study has a placebo (control) group. Study medication and treatment will be provided at no cost.
In this study, we are trying to determine what the effects of taking aripirazole are on children and adolescents diagnosed with autism spectrum disorder who have maladaptive behaviors such as hyperactivity, irritability, aggression, or anxiety. By treating children with aripriprazole, we hope to improve overall functioning for our study participants. If you think that your child might be eligible for this study or would like more information, please call the ASPIRE research hotline at 1-800-708-0048. Ages: 30 months - 17 years Note: Study medication and treatment will be provided free of charge
PREVENT: Metformin Mitigation Of Atypical Antipsychotic-Induced Metabolic Dysregulation In Adolescent Youths The purpose of this study is to determine whether starting metformin in conjunction with a second-generation antipsychotic (SGA) and providing information about healthy eating and activity will prevent or reduce the amount of weight gain and the metabolic changes typically seen with second-generation antipsychotic medication. Read more >> Ages: 10 - 17 years [back to top] |
|

